[VOD AVAILABLE] Clinical Conversations: Prediabetes – Black, White & Gray
Speakers
Rod Jackson, MBChB, PhD
Faculty of Medical and Health Sciences, Epidemiology and Biostatistics
University of Auckland, New Zealand
Elizabeth Selvin, PhD
Professor, Department of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Lecture Abstract
Prediabetes is often described as the precursor to type 2 diabetes, with screening and treatment practices in place to improve patient outcomes. By identifying at-risk patients, combining dietary and lifestyle changes with drug therapy can circumvent disease progression. However, some argue that prediabetes is a controversial diagnostic label lacking both validation and clinical relevance. This event will lay out pro and con arguments to debate the existence and clinical value of the prediabetic label.
Understanding pros and cons of accepting “prediabetes” as a diagnostic entity.
- Hear key points to support prediabetes as a valuable diagnostic entity with preventative benefits.
- Hear key points to counter that prediabetes is a useless label, devoid of clinical relevance.
- Select the debate position that most effectively defends and substantiates the relevance of the prediabetic label.
We hoped you have enjoyed the webinar and gained new insights!
May we request your time for a short survey?
![[VOD AVAILABLE] Automated Urine Analyser for Rapid Differentiation between Glomerular and Non-Glomerular Haematuria: A New Era in Haematuria Evaluation](https://www.sysmex-ap.com/wp-content/uploads/2024/10/kidney-825x510.jpg)
